Elanco Animal Health
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
- Total institutional ownership fell 2.4 percentage points.
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 111.90% -2.42pp
- Institutions
- 621 +12
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 48 buys · 2 sells
| Name | Role | Stake |
|---|---|---|
| Jeffrey Simmons | Chief Executive Officer | 0.37% |
| Ramiro Cabral | Executive VP & President of Elanco International | 0.04% |
| Ellen de Brabander | Executive Vice President of Research, Development & Regulatory Affairs | 0.04% |
| David Kinard | Former Executive Vice President of Human Resources, Communications & Administration | 0.04% |
| Roy Hoover | Former Independent Director | 0.04% |
| Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | 0.03% |
| Grace McArdle | Executive Vice President of Manufacturing & Quality | 0.02% |
| Timothy Bettington | Executive Vice President of Center of Strategic Growth | 0.02% |
| Shiv O'Neill | Executive Vice President, General Counsel & Corporate Secretary | 0.02% |
| Todd Young | Former Chief Financial Officer | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-29 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +122 | -- |
| 2026-10-29 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
| 2026-10-29 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +64 | -- |
| 2026-10-15 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +120 | -- |
| 2026-10-15 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
| 2026-10-15 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +62 | -- |
| 2026-10-14 | Timothy Bettington | Executive Vice President of Center of Strategic Growth | Automatic Disposition | -4,350 | $23.00 |
| 2026-10-14 | Timothy Bettington | Executive Vice President of Center of Strategic Growth | Intent to Sell (Form 144) | -4,350 | $23.00 |
| 2026-10-01 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +127 | -- |
| 2026-10-01 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
| 2026-10-01 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +66 | -- |
| 2026-09-29 | Kapila Anand | Independent Director | Other Derivative Acquisition | +642 | -- |
| 2026-09-17 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +126 | -- |
| 2026-09-17 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
| 2026-09-17 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +65 | -- |
| 2026-09-03 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +115 | -- |
| 2026-09-03 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
| 2026-09-03 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +60 | -- |
| 2026-08-20 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +117 | -- |
| 2026-08-20 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.
Elanco Animal Health discussion 0 comments